Document is current
Any future updates will be listed below
-
Authors
,
Hosogaya, Naoki
Miyazaki, Taiga https://orcid.org/0000-0002-0962-5758
Fukushige, Yuri
Takemori, Sachiko
Morimoto, Shinpei
Yamamoto, Hiroshi
Hori, Makoto
Kurokawa, Tomoya
Kawasaki, Yohei
Hanawa, Michiko
Fujii, Yasuhisa
Hanaoka, Hideki
Iwami, Shingo
Watashi, Koichi
Yamagoe, Satoshi
Miyazaki, Yoshitsugu
Wakita, Takaji
Izumikawa, Koichi
Yanagihara, Katsunori
Mukae, Hiroshi
Kohno, Shigeru
-
Funding
Funding for this research was provided by:
the Health and Labor Sciences Research Grants program (20HA1008)
- License Information
-
More Information
Article History
Received: 16 April 2021
Accepted: 17 April 2021
First Online: 28 April 2021
Declarations
:
: The protocol was approved by the Nagasaki University Hospital Institutional Review Board (approval number: I20-001) on May 25, 2020, and by each local Institutional Review Board. The authors certify that this trial has received ethical approval from the appropriate ethics committees of all the study sites.Participants will be provided with the information regarding the study by their respective infectious disease specialists and requested to sign an informed consent form if they are willing to participate. Participants should have the ability to understand and be willing to sign a written informed consent document to accept randomization to either intervention arm.
: Not applicable.
: TM, KI, KY, HM, and SK have received lecture honoraria and research grants from Pfizer Inc. outside the submitted work. The other authors declare that they have no competing interests.
